{"id":"W4362657687","doi":"10.1001/jamaoncol.2023.0147","title":"Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Université de Montréal; University of Alberta","funders":"National Institute for Health and Care Research; Seagen; MacroGenics; Mirati Therapeutics; Kowa Company; Sanofi; EMD Serono; Rakuten Medical; Bristol-Myers Squibb; AstraZeneca; Pfizer; Coherus Biosciences","keywords":"Medicine; Nivolumab; Ipilimumab; Head and neck; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Metastatic melanoma; Basal cell; Expanded access; Head and neck cancer; Melanoma; Dermatology; Immunotherapy; Surgery; Radiation therapy; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001957127,0.0001732114,0.00121616,0.0001003177,0.00008481563,0.000002084896,0.00006752017,0.000093396,0.00002069867],"category_scores_gemma":[0.0002018598,0.0001063953,0.0001193055,0.0002517489,0.0003233438,0.00002276053,0.00008600938,0.00006634058,0.000001090456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002401775,"about_ca_system_score_gemma":0.0004824114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004407967,"about_ca_topic_score_gemma":0.0008333782,"domain_scores_codex":[0.9986774,0.0001064583,0.0005325307,0.000266506,0.0001529477,0.0002642067],"domain_scores_gemma":[0.9982908,0.0009618154,0.0002534933,0.0002745982,0.0001364623,0.0000827644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1357871,0.007265874,0.04045359,0.008443674,0.001061157,0.0001685904,0.03805959,0.0000503417,0.01337148,0.0003101498,0.01313741,0.7418911],"study_design_scores_gemma":[0.169408,0.1069469,0.6471447,0.0005013638,0.001866556,0.0001457893,0.003344884,0.00171593,0.0198942,0.00009971659,0.04862072,0.0003112706],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913592,0.003899025,0.000008785849,0.002294683,0.0002204301,0.001452673,0.000145578,0.00001450458,0.000605153],"genre_scores_gemma":[0.9969875,0.00143401,0.0004748589,0.00007137904,0.00005819454,0.0001005677,0.00001409118,0.00001930752,0.000840124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7415798,"threshold_uncertainty_score":0.4338674,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05209509396336871,"score_gpt":0.3452510310749039,"score_spread":0.2931559371115352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}